Global Vitamin D Therapy Market
Vitamin D is defined as the fat-soluble vitamin which is responsible for maintaining healthy bones & teeth. Although our body cannot produce Vitamin D, it is mainly obtained by the cutaneous production during sun exposure. The deficiency of vitamin D causes to bone pain & weakened muscles. Vitamin D therapy is provided to treat various conditions including rickets, muscle weakness, osteoporosis, skin diseases, and others.
Market Drivers
The increase in target patient population is the key driving factor which expected to boost the global vitamin D therapy market growth over the forecast period. Furthermore, the growing awareness about vitamin D deficiency, the rise in patient compliance to oral medications, growing prevalence of hypovitaminosis D, sedentary lifestyles, aging population, and lack of exposure to sun are some prominent factors which expected to drive the global vitamin D therapy market growth. Moreover, strategic acquisitions and mergers among companies contribute to the growth of the vitamin D therapy market. For Instance, in 2018, GSK completed the buyout of Novartis’ 36.5% stake in Consumer Healthcare Joint Venture as well as GSK had entered into collaboration with Pfizer to form a consumer health care joint venture which would provide a range of products in vitamin & mineral supplements, therapeutic oral health, skin health, respiratory, pain relief, and digestive health, and others.
Also, the rise in use of vitamin D in the treatment of diseases is expected to provide a significant opportunity to the market of vitamin D therapy. For Instance, research article published in “Clinical Breast Cancer”, a magazine published by Elsevier found that vitamin D supplement intake with chemotherapy can advance disease-free survival in women with HER2+ breast cancer. The study reveals that patients who consumed Vitamin D supplements during treatment have better survival as compared to the patients who did not take vitamin D supplements. This research is expected to propel the Vitamin D therapy market growth in near future.
Market Restraints
The increase in cases of a medical condition associated with the excessive consumption of Vitamin D is expected to restrict the market growth of Vitamin D therapy market. High level of Vitamin D in the body can cause Vitamin D toxicity commonly called as Hypervitaminosis D. Though it is rare, but the serious condition can result in a buildup of excess calcium in the blood which is called as hypercalcemia. Therefore, excessive consumption of Vitamin D can occur serious medical conditions, this factor is anticipated to hamper the market growth of Vitamin D therapy market.
Market Segmentation
The Global Vitamin D Therapy Market is segmented into route of administration such as Oral, and Parenteral. The oral route is anticipated to register the largest share and highest CAGR during the forecast period. Due to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route.
Further, market is segmented into application such as Rickets, Muscle Weakness, Osteoporosis, Skin Diseases, and Others. The osteoporosis segment is anticipated to register the highest growth over the forecast period. This growth can be attributed to the growing incidence of falls & fractures in senior adults due to the elevated levels of parathyroid hormones and the poor absorption of calcium from their diets.
Regional Analysis
The Global Vitamin D Therapy Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The Asia Pacific is expected to expand at the highest CAGR during the forecast period, owing to the awareness about vitamin D deficiency as well as supportive government policies & programs for the implementation of vitamin D deficiency treatment plans, sedentary lifestyles, growing incidence of vitamin D deficiency, decreasing sun exposure, atypical diets, and rising malnutrition levels.
Also, the North America is anticipated to dominates the vitamin D therapy market during this forecast timeline. Due to the presence of leading players based in the United States, focus on research activities to develop more patient compliant products with enhanced efficiency along with the government support & the increase in healthcare expenditure contributing to its outstanding market revenue share in the overall market growth.
Key Players
Various key players are listed in this report such as Abbott Laboratories, Novartis International AG, Torrent Pharmaceuticals Ltd., Merck & Co., Inc., Sanofi, Pfizer, Inc., Cadila Healthcare Ltd., Sun Pharmaceutical Industries Ltd, Biotics Research Corporation, Alkem Laboratories Ltd, etc. Abbott Laboratories has a global distribution network & a good brand reputation among end users. The company’s strong presence as well as wide distribution channels across the world have helped it to maintain its leading position in the market. The company focusing on the mergers & acquisitions, with strategic alliances such as technology, licensing, to obtain an edge over competitors.
Market Taxonomy
By Route of Administration
By Application
By Region
Key Questions Addressed by the Report
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Vitamin D Therapy Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Vitamin D Therapy Market, Route of Administration
5.1 Y-o-Y Growth Comparison, Route of Administration
5.2 Global Vitamin D Therapy Market Share Analysis, Route of Administration
5.3 Global Vitamin D Therapy Market Size and Forecast, Route of Administration
5.3.1 Oral
5.3.2 Parenteral
6 Global Vitamin D Therapy Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Vitamin D Therapy Market Share Analysis, By Application
6.3 Global Vitamin D Therapy Market Size and Forecast, By Application
6.3.1 Rickets
6.3.2 Muscle Weakness
6.3.3 Osteoporosis
6.3.4 Skin Diseases
6.3.5Others
7Global Vitamin D Therapy Market, By Region
7.1 Global Vitamin D Therapy Market Share Analysis, By Region
7.2 Global Vitamin D Therapy Market Share Analysis, By Region
7.3 Global Vitamin D Therapy Market Size and Forecast, By Region
8North America Vitamin D Therapy Market Analysis and Forecast (2020 – 2030)
8.1 Introduction
8.2 North America Vitamin D Therapy Market Share Analysis, Route of Administration
8.3 North America Vitamin D Therapy Market Size and Forecast, By Application
8.4 North America Vitamin D Therapy Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9Europe Vitamin D Therapy Market Analysis and Forecast (2020 – 2030)
9.1 Introduction
9.2 Europe Vitamin D Therapy Market Share Analysis, Route of Administration
9.3 Europe Vitamin D Therapy Market Size and Forecast, By Application
9.4 Europe Vitamin D Therapy Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Vitamin D Therapy Market Analysis and Forecast (2020 – 2030)
10.1 Introduction
10.2 Asia Pacific Vitamin D Therapy Market Share Analysis, Route of Administration
10.3 Asia Pacific Vitamin D Therapy Market Size and Forecast, By Application
10.4 Asia Pacific Vitamin D Therapy Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Vitamin D Therapy Market Analysis and Forecast (2020 – 2030)
11.1 Introduction
11.2 Latin America Vitamin D Therapy Market Share Analysis, Route of Administration
11.3 Latin America Vitamin D Therapy Market Size and Forecast, By Application
11.4 Latin America Vitamin D Therapy Market Size and Forecast, By Country
12Middle East Vitamin D Therapy Market Analysis and Forecast (2020 – 2030)
12.1 Introduction
12.2 Middle East Vitamin D Therapy Market Share Analysis, Route of Administration
12.3 Middle East Vitamin D Therapy Market Size and Forecast, By Application
12.4 Middle East Vitamin D Therapy Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 Abbott Laboratories
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Novartis International AG
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Torrent Pharmaceuticals Ltd
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Merck & Co., Inc
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Sanofi
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Pfizer, Inc.
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Cadila Healthcare Ltd
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Sun Pharmaceutical Industries Ltd
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Biotics Research Corporation
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Alkem Laboratories Ltd
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategie
